{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "firstTradeDateMilliseconds": 1615987800000, "priceHint": 4, "exchange": "NCM", "shortName": "Better Therapeutics, Inc.", "longName": "Better Therapeutics, Inc.", "messageBoardId": "finmb_598952840", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.17909606, "regularMarketPrice": 0.7831, "marketState": "PRE", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.0013999939, "regularMarketTime": 1684180800, "regularMarketDayHigh": 0.899, "regularMarketDayRange": "0.76 - 0.899", "regularMarketDayLow": 0.76, "regularMarketVolume": 177771, "regularMarketPreviousClose": 0.7817, "bid": 0.0, "ask": 0.0, "bidSize": 12, "askSize": 10, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.899, "averageDailyVolume3Month": 127981, "averageDailyVolume10Day": 276100, "fiftyTwoWeekLowChange": 0.19410002, "fiftyTwoWeekLowChangePercent": 0.32954165, "fiftyTwoWeekRange": "0.589 - 2.8", "fiftyTwoWeekHighChange": -2.0169, "fiftyTwoWeekHighChangePercent": -0.7203215, "fiftyTwoWeekLow": 0.589, "fiftyTwoWeekHigh": 2.8, "earningsTimestamp": 1683808200, "earningsTimestampStart": 1691611200, "earningsTimestampEnd": 1692043200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.53, "epsForward": -1.48, "epsCurrentYear": -1.22, "priceEpsCurrentYear": -0.6418852, "sharesOutstanding": 31731100, "bookValue": -0.038, "fiftyDayAverage": 1.0436, "fiftyDayAverageChange": -0.26049995, "fiftyDayAverageChangePercent": -0.24961668, "twoHundredDayAverage": 1.416865, "twoHundredDayAverageChange": -0.633765, "twoHundredDayAverageChangePercent": -0.4473009, "marketCap": 27509206, "forwardPE": -0.52912164, "priceToBook": -20.607895, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "displayName": "Better Therapeutics", "symbol": "BTTX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "548 Market Street", "address2": "Suite 49404", "city": "San Francisco", "state": "CA", "zip": "94104", "country": "United States", "phone": "415 887 2311", "website": "https://www.bettertx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Mr. David P. Perry M.B.A.", "age": 54, "title": "Co-Founder & Exec. Chairman", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 260000, "fmt": "260k", "longFmt": "260,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Frank L. Karbe", "age": 54, "title": "CEO, Pres & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 533369, "fmt": "533.37k", "longFmt": "533,369"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mark A. Berman M.D.", "age": 47, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 573750, "fmt": "573.75k", "longFmt": "573,750"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kristin  Wynholds", "age": 50, "title": "Chief Product Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 519067, "fmt": "519.07k", "longFmt": "519,067"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 12785, "fmt": "12.79k", "longFmt": "12,785"}}, {"maxAge": 1, "name": "Mr. Mark  Heinen", "age": 52, "title": "Head of Fin. & CFO", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andres  Camacho", "title": "Sr. VP of Technology & Head of Engineering", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thiago Licias De Oliveira", "title": "Chief People Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Diane  Gomez-Thinnes", "title": "Chief Commercial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}